Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antacids
1.2.3 Pro-kinetic agents
1.2.4 H2 Receptor Blockers
1.2.5 Proton Pump Inhibitors (PPIs)
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2018-2033)
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Region
2.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Dynamics
2.3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2022
3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2024-2033)
5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2018-2033)
6.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023)
6.4 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2018-2033)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2018-2033)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
11.2.5 Eisai Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antacids
Table 3. Key Players of Pro-kinetic agents
Table 4. Key Players of H2 Receptor Blockers
Table 5. Key Players of Proton Pump Inhibitors (PPIs)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2018-2023)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2024-2033)
Table 12. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
Table 13. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
Table 16. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2022)
Table 19. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
Table 23. Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2024-2033)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2018-2023)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2024-2033)
Table 33. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 51. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. Eisai Company Detail
Table 54. Eisai Business Overview
Table 55. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 56. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Eisai Recent Development
Table 58. GSK Company Detail
Table 59. GSK Business Overview
Table 60. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 61. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023) & (US$ Million)
Table 62. GSK Recent Development
Table 63. Takeda Company Detail
Table 64. Takeda Business Overview
Table 65. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 66. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Takeda Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 71. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Antacids Features
Figure 4. Pro-kinetic agents Features
Figure 5. H2 Receptor Blockers Features
Figure 6. Proton Pump Inhibitors (PPIs) Features
Figure 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2022 VS 2033
Figure 9. Heartburn Case Studies
Figure 10. Acid reflux disorders Case Studies
Figure 11. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2022
Figure 16. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2022
Figure 18. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2018-2033)
Figure 32. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
Figure 47. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
Figure 48. GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
Figure 49. Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed